Abstract:Aim: The aim of this study was to evaluate the relationship between renal function and low-density lipoprotein cholesterol (LDL-C) goal achievement and compare the strategy of lipid-lowering therapy (LLT) among the patients with coronary artery disease (CAD) with different renal functions. Methods: In this study, we enrolled 933 Chinese patients with CAD from September 2020 to June 2021 admitted to the Cardiometabolic Center of Fuwai Hospital in Beijing consecutively. All individuals were divided into two groups based on their estimated glomerular filtration rate (eGFR). The multiple logistical regression analysis was performed to identify and compare the independent factors which impacted LDL-C goal achievement in the two groups after at least 3 months of treatment. Results: There were 808 subjects with eGFR ≥ 60 ml/min/1.73 m 2 who were divided into Group 1 (G1). A total of 125 patients with eGFR <60 ml/min/1.73 m 2 were divided into Group 2 (G2). The rate of LDL-C goal attainment (LDL-C <1.4 mmol/L) was significantly lower in G2 when compared with that in G1 (24.00% vs. 35.52%, P = 0.02), even though there was no significant difference in the aspect of LLT between the two groups (high-intensity LLT: 82.50% vs. 85.60% P = 0.40). Notably, in G1, the proportion of LDL-C goal achievement increased with the intensity of LLT (23.36% vs. 39.60% vs. 64.52% in the subgroup under low-/moderate-intensity LLT, or high-intensity LLT without proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor (PCSK9i), or high-intensity LLT with PCSK9i, respectively, P < 0.005). In addition, in G2, there was a trend that the rate of LDL-C goal achievement was higher in the subgroup under high-intensity LLT (26.60% in the subgroup under high-intensity LLT without PCSK9i and 25.00% in the subgroup under high-intensity LLT with PCSK9i) than that under low-/moderate-intensity LLT (15.38%, P = 0.49). Importantly, after multiple regression analysis, we found that eGFR <60 ml/min/1.73 m 2 [odds ratio (OR) 1.81; 95%CI, 1.15–2.87; P = 0.01] was an independent risk factor to impact LDL-C goal achievement. However, the combination strategy of LLT was a protective factor for LDL-C goal achievement independently (statin combined with ezetimibe: OR 0.42; 95%CI 0.30–0.60; P < 0.001; statin combined with PCSK9i: OR 0.15; 95%CI 0.07–0.32; P < 0.001, respectively). Conclusion: Impaired renal function (eGFR <60 ml/min/1.73 m 2 ) was an independent risk factor for LDL-C goal achievement in the patients with CAD. High-intensity LLT with PCSK9i could improve the rate of LDL-C goal achievement significantly. It should be suggested to increase the proportion of high-intensity LLT with PCSK9i for patients with CAD, especially those with impaired renal function.

Clinical Characteristics And Predictors Of Low-Density Lipoprotein Cholesterol Target Achievement In Chinese Han Patients With Coronary Artery Disease And Either Preserved Or Reduced Left Ventricular Ejection Fraction

Predictive value of the relative lymphocyte count in coronary heart disease

Association Between Non-High-density Lipoprotein Cholesterol and Coronary Artery Disease in Patients with Acute Coronary Syndrome: a Single-Centre Retrospective Cross-Sectional Analysis

Lower Baseline LDL Cholesterol Affects All-cause Mortality in Patients with First Percutaneous Coronary Intervention.

Achievement of Low-Density Lipoprotein Cholesterol Targets in Chinese Patients with Atherosclerotic Cardiovascular Disease after Receiving Statins and Ezetimibe

Clinical Outcomes Based on the Attainment of Low-Density Lipoprotein Cholesterol Targets in Patients with Acute Coronary Syndrome in Real-World Practice

Lipid goal attainment in post-acute coronary syndrome patients in China: Results from the 6-month real-world dyslipidemia international study II

Goal attainments and their discrepancies for low density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apo B) in over 2,000 Chinese patients with known coronary artery disease or type 2 diabetes.

Low HDL-C Predicts Risk and PCI Outcomes in the Han Chinese Population.

LIPID MANAGEMENT IN ACUTE CORONARY SYNDROME PATIENTS AMONG THE TIER THREE HOSPITALS

[Clinical Characteristics of Coronary Artery Disease Patients with Reduced Left Ventricular Ejection Fraction and Their Prognostic Analysis].

GW24-e2112 Goal Attainments and Their Discrepancies for LDL Cholesterol and Apolipoprotein B in over 2000 Chinese Hospitalised Patients with Known Coronary Artery Disease or Type 2 Diabetes Mellitus

Contemporary Management And Attainment Of Cholesterol Targets For Patients With Dyslipidemia In China

GW24-e3180 Ethnic Differences of Low-Density Lipoprotein Cholesterol Target-Goal Achievement in Patients with Stable Coronary Heart Disease Combined with Type 2 Diabetes Mellitus or Not at University Hospitals

A10827 Assessment of Left Ventricular Structure and Functional Abnormality and Association with Cardiovascular Risks in an Older Community-Dwelling Chinese Population

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions

Low LDL-C Levels Are Associated with Risk of Mortality in a Chinese Cohort Study

Reduced Heart Function Predicts Drug-Taking Compliance and Two-Year Prognosis in Chinese Patients with Stable Premature Coronary Artery Disease

Different Lipid Parameters in Predicting Clinical Outcomes in Chinese Statin-Naïve Patients after Coronary Stent Implantation.

Lipid Goal Attainment in Diabetes Mellitus Patients after Acute Coronary Syndrome: a Subanalysis of Dyslipidemia International Study II-China

[Low-Density Lipoprotein Cholesterol Target Goal Attainment Rate and Related Factors in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention].